{"id":"NCT00487539","sponsor":"Janssen Research & Development, LLC","briefTitle":"An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis","officialTitle":"A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-08","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2007-06-18","resultsPosted":"2014-02-17","lastUpdate":"2014-02-17"},"enrollment":1065,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Colitis, Ulcerative"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"Golimumab 100 mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Golimumab 200 mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Golimumab 400 mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Golimumab 50 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Golimumab 100 mg -> 50 mg","type":"EXPERIMENTAL"},{"label":"Golimumab 200 mg -> 100 mg","type":"EXPERIMENTAL"},{"label":"Golimumab 400 mg -> 200 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the effects (good and bad) of golimumab (CNTO 148) therapy in participants with ulcerative colitis (UC).","primaryOutcome":{"measure":"Number of Participants With Clinical Response at Week 6","timeFrame":"Baseline, Week 6","effectByArm":[{"arm":"Placebo","deltaMin":76,"sd":null},{"arm":"Golimumab 200 mg -> 100 mg","deltaMin":129,"sd":null},{"arm":"Golimumab 400 mg -> 200 mg","deltaMin":141,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":200,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Czechia","Denmark","France","Germany","Hungary","India","Israel","Japan","Lithuania","Netherlands","New Zealand","Poland","Romania","Russia","Serbia","Slovakia","South Africa","Sweden","Ukraine"]},"refs":{"pmids":["31982148","30721964","23735746"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":330},"commonTop":["Headache","Nasopharyngitis","Pyrexia","Nausea","Anaemia"]}}